EmendoBio Competitors or Alternatives

EmendoBio's top competitors include Spotlight Therapeutics, Beam and Editas Medicine.

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

EmendoBio's company profile

Naoya Satoh

CEO

- -
25 - 100
$61M
$100K - 5M
1
EmendoBio's Competitor - Spotlight Therapeutics logo

Mary Haak-Frendscho

President & CEO

90/100
25 - 100
$73.8M
$100K - 5M
2
EmendoBio's Competitor - Beam logo

John Evans

CEO

90/100
510
$806.5M
$63.5M
3
EmendoBio's Competitor - Editas Medicine logo

Gilmore ONeill

President & CEO

63/100
230
$473M
$32.3M

EmendoBio VS Spotlight Therapeutics

Spotlight Therapeutics is the top competitor of EmendoBio. Spotlight Therapeutics was founded in 2018, and its headquarters is in Hayward, California. Like EmendoBio, Spotlight Therapeutics also operates in the Biotechnology field. Spotlight Therapeutics has 25 fewer employees than EmendoBio.

EmendoBio VS Beam

Beam is seen as one of EmendoBio's top competitors. Beam was founded in Cambridge, Massachusetts} in 2017. Like EmendoBio, Beam also works within the Biotechnology field. Compared to EmendoBio, Beam generates $60.6M more revenue.

EmendoBio VS Editas Medicine

Editas Medicine is EmendoBio's #3 rival. Editas Medicine's headquarters is in Cambridge, Massachusetts, and was founded in 2013. Like EmendoBio, Editas Medicine also operates in the Biotechnology sector. Editas Medicine generates 1,114% of EmendoBio's revenue.

Frequently Asked Questions about EmendoBio

  1. Who are EmendoBio's top competitors?

    EmendoBio's top 3 competitors are Spotlight Therapeutics, Beam, Editas Medicine.
  2. Who is similar to EmendoBio?

    Spotlight Therapeutics is the most similar to EmendoBio. Beam and Editas Medicine are also similar to EmendoBio.
  1. Are EmendoBio and Spotlight Therapeutics competitors?

    Yes, Spotlight Therapeutics is one of EmendoBio’s top competitors.